Treating COVID-19 using Micro RNA
Over 7,805,583 people worldwide are susceptible to death because of infection by an encountered microscopic virus known as Coronavirus. Actually, it is a family of infectious viruses that was first discovered for about 50 years by a group of virologists. By time, COVID-19 has developed and adap...
Saved in:
Main Author: | Eskandar Kirolos |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Oran 1
2023-06-01
|
Series: | Journal de la Faculté de Médecine d'Oran |
Subjects: | |
Online Access: | https://www.Ajol.Info/index.php/jfmo/article/view/250063 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of exo-long noncoding RNA MALAT1 in OSCC in comparison to dysplastic and normal: A cross-sectional study
by: Ramya Sekar, et al.
Published: (2025-01-01) -
Exploring Echinacea angustifolia for anti-viral compounds against Zika virus RNA-dependent RNA polymerase: a computational study
by: Mai M. El-Daly, et al.
Published: (2025-02-01) -
An Overview on The Pandemic Coronavirus Disease 2019 (COVID-19) Outbreak
by: Mariwan Abdulla Hama Salih
Published: (2020-05-01) -
Extracecellulr vesicles (EVs) microRNAs (miRNAs) derived from mesenchymal stem cells (MSCs) in osteoarthritis (OA); detailed role in pathogenesis and possible therapeutics
by: Seyede Sara Pakdaman Kolour, et al.
Published: (2025-02-01) -
Phthalate exposure induces microRNA-5010/Nrf2-EGR1/GDF15 signaling expression in prostate cancer
by: Yuh-Shyan Tsai, et al.
Published: (2025-01-01)